Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contacting medical devices.

The current state-of-the-art with respect to the preparation, characterization and biomedical applications of novel nitric oxide (NO) releasing or generating polymeric materials is reviewed. Such materials show exceptional promise as coatings to prepare a new generation of medical devices with superior biocompatiblity. Nitric oxide is a well-known inhibitor of platelet adhesion and activation, as well as a potent inhibitor of smooth muscle cell proliferation. Hence, polymers that release or generate NO locally at their surface exhibit greatly enhanced thromboresistivity and have the potential to reduce neointimal hyperplasia caused by device damage to blood vessel walls. In this review, the use of diazeniumdiolates and nitrosothiols as NO donors within a variety polymeric matrixes are summarized. Such species can either be doped as discrete NO donors within polymeric films, or covalently linked to polymer backbones and/or inorganic polymeric filler particles that are often employed to enhance the strength of biomedical polymers (e.g., fumed silica or titanium dioxide). In addition, very recent efforts to create catalytic polymers possessing immobilized Cu(II) sites capable of generating NO from endogenous oxidized forms of NO already present in blood and other physiological fluids (nitrite and nitrosothiols) are discussed. Preliminary literature data illustrating the efficacy of the various NO release/generating polymers as coatings for intravascular sensors, extracorporeal blood loop circuits, and arteriovenous grafts/shunts are reviewed.

[1]  D. L. Williams,et al.  Reaction of ascorbic acid with S-nitrosothiols: clear evidence for two distinct reaction pathways , 2000 .

[2]  Jennifer L West,et al.  Effects of nitric oxide releasing poly(vinyl alcohol) hydrogel dressings on dermal wound healing in diabetic mice , 2002, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[3]  E J Topol,et al.  The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. , 1992, Journal of the American College of Cardiology.

[4]  M. Lewis,et al.  The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty. , 1995, Cardiovascular research.

[5]  Mark E. Meyerhoff,et al.  Preparation and characterization of implantable sensors with nitric oxide release coatings , 2003 .

[6]  R. Colman,et al.  Chapter 3 Mechanisms of thrombus formation and dissolution , 1993 .

[7]  A. Butler,et al.  Identification of Cu+ as the effective reagent in nitric oxide formation from S-nitrosothiols (RSNO) , 1996 .

[8]  K. M. Davies,et al.  Piperazine as a Linker for Incorporating the Nitric Oxide-Releasing Diazeniumdiolate Group into Other Biomedically Relevant Functional Molecules. , 1999, Journal of Organic Chemistry.

[9]  M. Meyerhoff,et al.  Catalytic generation of nitric oxide from nitrite at the interface of polymeric films doped with lipophilic CuII-complex: a potential route to the preparation of thromboresistant coatings. , 2004, Biomaterials.

[10]  R. Drago,et al.  The Reaction of Nitrogen(II) Oxide with Various Primary and Secondary Amines , 1961 .

[11]  A. Narayana,et al.  Vascular brachytherapy for hemodialysis vascular access dysfunction: exploring an unmet clinical need. , 2003, The Journal of invasive cardiology.

[12]  S. Moncada,et al.  The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide , 1987, British journal of pharmacology.

[13]  M. Meyerhoff,et al.  Synthesis and characterization of polymethacrylate-based nitric oxide donors. , 2002, Journal of the American Chemical Society.

[14]  S. M. Shishido,et al.  Polyethylene Glycol Matrix Reduces the Rates of Photochemical and Thermal Release of Nitric Oxide from S-nitroso-N-acetylcysteine , 2000, Photochemistry and photobiology.

[15]  M. Meyerhoff,et al.  Spontaneous catalytic generation of nitric oxide from S-nitrosothiols at the surface of polymer films doped with lipophilic copperII complex. , 2003, Journal of the American Chemical Society.

[16]  K. M. Davies,et al.  Boundary layer infusion of nitric oxide reduces early smooth muscle cell proliferation in the endarterectomized canine artery. , 1997, The Journal of surgical research.

[17]  A. Narayana,et al.  Hemodialysis Vascular Access Dysfunction: From Pathophysiology to Novel Therapies , 2003, Blood Purification.

[18]  J. Tanguay,et al.  Platelets and restenosis. , 2000, Journal of the American College of Cardiology.

[19]  R. Tamargo,et al.  Prevention and Reversal of Experimental Posthemorrhagic Vasospasm by the Periadventitial Administration of Nitric Oxide from a Controlled-release Polymer , 2001, Neurosurgery.

[20]  D. Wise Biomaterials engineering and devices : human applications , 2000 .

[21]  H. Bayır,et al.  [30] Quantitation of S-nitrosothiols in cells and biological fluids , 2002 .

[22]  R. Drago,et al.  The Reaction of Nitrogen(II) Oxide with Diethylamine , 1960 .

[23]  W. Loh,et al.  Thermal and photochemical nitric oxide release from S-nitrosothiols incorporated in Pluronic F127 gel: potential uses for local and controlled nitric oxide release. , 2003, Biomaterials.

[24]  K. Kent,et al.  Novel approaches for the prevention of restenosis , 2000, Expert opinion on investigational drugs.

[25]  M. Meyerhoff,et al.  Nitric oxide-releasing fluorescence-based oxygen sensing polymeric films. , 2002, Analytical chemistry.

[26]  M. Meyerhoff,et al.  More lipophilic dialkyldiamine-based diazeniumdiolates: synthesis, characterization, and application in preparing thromboresistant nitric oxide release polymeric coatings. , 2003, Journal of medicinal chemistry.

[27]  M. Meyerhoff,et al.  Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release. , 2000, Biomaterials.

[28]  P. Serruys,et al.  Sirolimus-Eluting Stent for the Treatment of In-Stent Restenosis: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study , 2003, Circulation.

[29]  D. L. Williams,et al.  The Chemistry of S-Nitrosothiols , 1999 .

[30]  E. Fleck,et al.  Rapamycin inhibits E2F-dependent expression of minichromosome maintenance proteins in vascular smooth muscle cells. , 2003, Biochemical and biophysical research communications.

[31]  Mary E. Robbins,et al.  Preparation of Nitric Oxide (NO)-Releasing Sol−Gels for Biomaterial Applications , 2003 .

[32]  M. Meyerhoff,et al.  Thromboresistant Chemical Sensors Using Combined Nitric Oxide Release/Ion Sensing Polymeric Films , 1997 .

[33]  C. Bamford,et al.  Modification of Biomaterials to Improve Blood Compatibility , 1992, The International journal of artificial organs.

[34]  D. Grijpma,et al.  In vitro degradation of Polyactive 1000PEOT70PBT30 devices. , 2002, Biomaterials.

[35]  M. Meyerhoff,et al.  Improving the thromboresistivity of chemical sensors via nitric oxide release: fabrication and in vivo evaluation of NO-releasing oxygen-sensing catheters. , 2000, Analytical chemistry.

[36]  R. Bartlett,et al.  Nitric oxide releasing silicone rubbers with improved blood compatibility: preparation, characterization, and in vivo evaluation. , 2002, Biomaterials.

[37]  A. Narayana,et al.  Hemodialysis vascular access dysfunction from basic biology to clinical intervention. , 2002, Advances in renal replacement therapy.

[38]  R. Bartlett,et al.  Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers , 2000, Critical care medicine.

[39]  M. Simmons,et al.  Transdermal delivery of nitric oxide from diazeniumdiolates. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[40]  S. Heffelfinger,et al.  Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. , 2001, Kidney international.

[41]  J L West,et al.  Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation. , 2000, Biomaterials.

[42]  A. Narayana,et al.  Aggressive venous neointimal hyperplasia in a pig model of arteriovenous graft stenosis. , 2002, Kidney international.

[43]  J. Braybrook,et al.  Biocompatibility assessment of medical devices and materials , 1997 .

[44]  J. Joseph,et al.  Mechanism of Nitric Oxide Release from S-Nitrosothiols* , 1996, The Journal of Biological Chemistry.

[45]  José A. Olabe,et al.  Photodelivery of Nitric Oxide from a Nitrosothiol-Derivatized Surface , 2000 .

[46]  K. M. Davies,et al.  Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor. , 1996, Journal of medicinal chemistry.

[47]  D. Wink,et al.  New nitric oxide-releasing zwitterions derived from polyamines , 1993 .

[48]  S Moncada,et al.  The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. , 1987, Biochemical and biophysical research communications.

[49]  S. Kaul,et al.  Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation. , 1998, The Journal of thoracic and cardiovascular surgery.

[50]  D. Smith,et al.  Incorporation of nitric oxide-releasing crosslinked polyethyleneimine microspheres into vascular grafts. , 1997, Journal of biomedical materials research.

[51]  J. Vane,et al.  Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[52]  M. Gorbet,et al.  What really is blood compatibility? , 2000, Journal of biomaterials science. Polymer edition.

[53]  Mark E Meyerhoff,et al.  In vivo biocompatibility and analytical performance of intravascular amperometric oxygen sensors prepared with improved nitric oxide-releasing silicone rubber coating. , 2002, Analytical chemistry.

[54]  Randy S. Lewis,et al.  Improved haemocompatibility of cysteine-modified polymers via endogenous nitric oxide. , 2002, Biomaterials.

[55]  S. Goldstein,et al.  Kinetics of Nitric Oxide Autoxidation in Aqueous Solution in the Absence and Presence of Various Reductants. The Nature of the Oxidizing Intermediates , 1995 .

[56]  G. Mintz,et al.  Coronary in-stent restenosis - predictors, treatment and prevention. , 2000, European heart journal.

[57]  M. Meyerhoff,et al.  More Biocompatible Electrochemical Sensors Using Nitric Oxide Release Polymers , 1999 .

[58]  M. Lewis,et al.  Endothelium-derived relaxing factor inhibits platelet adhesion to cultured porcine endocardial endothelium. , 1992, European journal of pharmacology.

[59]  R. Bartlett,et al.  Nitric oxide-releasing fumed silica particles: synthesis, characterization, and biomedical application. , 2003, Journal of the American Chemical Society.

[60]  J. Liao,et al.  modeling in physiology Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model , 1998 .

[61]  M. Meyerhoff,et al.  Controlled photoinitiated release of nitric oxide from polymer films containing S-nitroso-N-acetyl-DL-penicillamine derivatized fumed silica filler. , 2004, Journal of the American Chemical Society.

[62]  K. M. Davies,et al.  Nitric oxide-releasing polymers containing the [N(O)NO]- group. , 1996, Journal of medicinal chemistry.

[63]  M. Grisham,et al.  Dynamic state of S-nitrosothiols in human plasma and whole blood. , 2000, Free radical biology & medicine.

[64]  E Regar,et al.  Stent development and local drug delivery. , 2001, British medical bulletin.

[65]  Patrick W Serruys,et al.  Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. , 2003, Journal of the American College of Cardiology.

[66]  R. Tamargo,et al.  Prevention of Experimental Cerebral Vasospasm by Intracranial Delivery of a Nitric Oxide Donor From a Controlled-Release Polymer: Toxicity and Efficacy Studies in Rabbits and Rats , 2002, Stroke.